Skip to main content

European Heart Journal - Cardiovascular Pharmacotherapy

  • Share

An official journal of the European Society of Cardiology (ESC), and the ESC Working Group on Cardiovascular Pharmacotherapy, European Heart Journal - Cardiovascular Pharmacotherapy is an international, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.

European Heart Journal - Cardiovascular Pharmacotherapy offers access to a global audience of clinicians, physicians, researchers, and policy makers. Our advertising channels provide the flexibility to tailor campaigns to your specific requirements, including geo-targeting to any country/region in the world.

European Heart Journal - Cardiovascular Pharmacotherapy is part of our wider ESC Journal Family, allowing you to select a single title, or to leverage our cardiology audiences across the most relevant publications to maximise the reach of your campaign.

The media kit details the average monthly global audience, but let us know your specific campaign requirements and we can send you the latest reports.

Impact Factor

5.4

Ranking

34 out of 354*
*in Cardiac & Cardiovascular Systems

CiteScore

10.1

For your tailored solution…

Digital Advertising

50,667
Impressions
22,025
Uniques
  • 12%
    USA*
  • 2%
    Canada*
  • 6%
    UK*
  • 50%
    Rest of Europe*
  • 29%
    Rest of World*

*Impressions by region

Contact your rep for digital pricing and to confirm which digital options this journal offers.

Print

Rates

Special position premiums

Schedule

Print specifications